COSCIENS Biopharma Stock Forward View - Relative Strength Index
| CSCI Stock | 2.03 0.03 1.46% |
COSCIENS Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of COSCIENS Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 30th of January 2026, the RSI of COSCIENS Biopharma's share price is approaching 46 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling COSCIENS Biopharma, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
Quarterly Revenue Growth 0.176 |
Using COSCIENS Biopharma hype-based prediction, you can estimate the value of COSCIENS Biopharma from the perspective of COSCIENS Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
COSCIENS Biopharma after-hype prediction price | USD 2.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of COSCIENS Biopharma to cross-verify your projections. COSCIENS Biopharma Additional Predictive Modules
Most predictive techniques to examine COSCIENS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for COSCIENS using various technical indicators. When you analyze COSCIENS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 44.32 | 44.32 |
| Check COSCIENS Biopharma Volatility | Backtest COSCIENS Biopharma | Information Ratio |
COSCIENS Biopharma Trading Date Momentum
| On January 30 2026 COSCIENS Biopharma was traded for 2.03 at the closing time. The top price for the day was 2.03 and the lowest listed price was 2.03 . There was no trading activity during the period 0.0. Lack of trading volume on January 30, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
| Compare COSCIENS Biopharma to competition |
Other Forecasting Options for COSCIENS Biopharma
For every potential investor in COSCIENS, whether a beginner or expert, COSCIENS Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. COSCIENS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in COSCIENS. Basic forecasting techniques help filter out the noise by identifying COSCIENS Biopharma's price trends.COSCIENS Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with COSCIENS Biopharma stock to make a market-neutral strategy. Peer analysis of COSCIENS Biopharma could also be used in its relative valuation, which is a method of valuing COSCIENS Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
COSCIENS Biopharma Market Strength Events
Market strength indicators help investors to evaluate how COSCIENS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading COSCIENS Biopharma shares will generate the highest return on investment. By undertsting and applying COSCIENS Biopharma stock market strength indicators, traders can identify COSCIENS Biopharma entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2.03 | |||
| Day Typical Price | 2.03 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) | |||
| Relative Strength Index | 44.32 |
COSCIENS Biopharma Risk Indicators
The analysis of COSCIENS Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in COSCIENS Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cosciens stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.39 | |||
| Semi Deviation | 10.83 | |||
| Standard Deviation | 14.83 | |||
| Variance | 219.98 | |||
| Downside Variance | 186.1 | |||
| Semi Variance | 117.35 | |||
| Expected Short fall | (9.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for COSCIENS Biopharma
The number of cover stories for COSCIENS Biopharma depends on current market conditions and COSCIENS Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that COSCIENS Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about COSCIENS Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
COSCIENS Biopharma Short Properties
COSCIENS Biopharma's future price predictability will typically decrease when COSCIENS Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of COSCIENS Biopharma often depends not only on the future outlook of the potential COSCIENS Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. COSCIENS Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 16.4 M |
Check out Historical Fundamental Analysis of COSCIENS Biopharma to cross-verify your projections. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is there potential for Biotechnology market expansion? Will COSCIENS introduce new products? Factors like these will boost the valuation of COSCIENS Biopharma. Projected growth potential of COSCIENS fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.54) | Revenue Per Share | Quarterly Revenue Growth 0.176 | Return On Assets | Return On Equity |
Understanding COSCIENS Biopharma requires distinguishing between market price and book value, where the latter reflects COSCIENS's accounting equity. The concept of intrinsic value—what COSCIENS Biopharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push COSCIENS Biopharma's price substantially above or below its fundamental value.
It's important to distinguish between COSCIENS Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding COSCIENS Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, COSCIENS Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.